A Perspective Study of Cancer-related Fatigue in Gynecologic Cancer Patients Under Chemotherapy
Paraules clau
Resum
Descripció
About 60 gynecologic cancer patients' medical records are expected to collect and analyze in this retrospective study. The data collection from medical records of gynecologic cancer patients who had received chemotherapy with or without prescription drug treatment for cancer-related fatigue include the demographic information (e.g., height, weight, age, sex, tumor stage, time from tumor diagnoses, prescription drug of cancer-related fatigue treatment and chemotherapy toxicities), the diagnosis and severity of cancer-related fatigue, functional assessment of cancer therapy and so on.
Dates
Darrera verificació: | 01/31/2018 |
Primer enviat: | 03/19/2017 |
Inscripció estimada enviada: | 03/19/2017 |
Publicat per primera vegada: | 03/23/2017 |
Última actualització enviada: | 02/10/2018 |
Publicació de l'última actualització: | 02/12/2018 |
Data d'inici de l'estudi real: | 10/18/2016 |
Data estimada de finalització primària: | 12/30/2018 |
Data estimada de finalització de l’estudi: | 12/30/2018 |
Condició o malaltia
Fase
Grups de braços
Braç | Intervenció / tractament |
---|---|
Gynecologic cancer patients Gynecologic cancer patients under chemotherapy |
Criteris d'elegibilitat
Edats elegibles per estudiar | 20 Years Per a 20 Years |
Sexes elegibles per estudiar | Female |
Mètode de mostreig | Non-Probability Sample |
Accepta voluntaris saludables | Sí |
Criteris | Inclusion Criteria: - Gynecologic cancer patients under chemotherapy. - aged 20 and above. Exclusion Criteria: - Patients who had been enrolled for other investigational drug trials within the data collection period of this study. |
Resultat
Mesures de resultats primaris
1. Cancer-related fatigue evaluation by brief fatigue inventory-Taiwanese form(BFI-T) [Change from baseline cancer-related fatigue at each chemotherapy cycle (each cycle is 21 or 28 days)]
Mesures de resultats secundaris
1. Quality of life assessments by functional assessment of cancer therapy-general 7 (FACT-G7) [Change from baseline Quality of life at each chemotherapy cycle (each cycle is 21 or 28 days)]
Altres mesures de resultats
1. Cytokine and immune markers [Change from baseline cytokine and immune index at each chemotherapy cycle (each cycle is 21 or 28 days)]